Lv21
140 积分 2022-04-30 加入
Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty
46分钟前
已完结
The Chaos of Choice in Large B-cell Lymphoma: A Call to Harmonize First-line Trial Design
3天前
已关闭
Real-Life Effectiveness, Safety, and Growth Outcomes of Dupilumab in Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis: A Multicenter Retrospective Study from an Italian NPP Program
1个月前
已完结
Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study
1个月前
已完结
儿童特应性皮炎诊疗新思考：现状、挑战与展望
1个月前
已关闭
Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)
3个月前
已完结
Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)
3个月前
已完结
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
3个月前
已完结
A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis
3个月前
已完结
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
3个月前
已完结
皖公网安备34019202002308
